227 related articles for article (PubMed ID: 36243282)
41. Improvement in eosinophilic esophagitis when using dupilumab for other indications or compassionate use.
Spergel BL; Ruffner MA; Godwin BC; Liacouras CA; Cianferoni A; Gober L; Hill DA; Brown-Whitehorn TF; Chaiboonma K; Aceves SA; Muir AM; Spergel JM
Ann Allergy Asthma Immunol; 2022 May; 128(5):589-593. PubMed ID: 35085819
[TBL] [Abstract][Full Text] [Related]
42. Systematic Review of Outcome Measures Used in Observational Studies of Adults with Eosinophilic Esophagitis.
Schoepfer AM; Schürmann C; Trelle S; Zwahlen M; Ma C; Chehade M; Dellon ES; Jairath V; Feagan BG; Bredenoord AJ; Biedermann L; Greuter T; Schreiner P; Straumann A; Safroneeva E
Int Arch Allergy Immunol; 2021; 182(12):1169-1193. PubMed ID: 34544078
[TBL] [Abstract][Full Text] [Related]
43. Current options and investigational drugs for the treatment of eosinophilic esophagitis.
Tamarit-Sebastian S; Ferrer-Soler FM; Lucendo AJ
Expert Opin Investig Drugs; 2022 Feb; 31(2):193-210. PubMed ID: 35072575
[TBL] [Abstract][Full Text] [Related]
44. The role of maintenance therapy in eosinophilic esophagitis: who, why, and how?
Philpott H; Dellon ES
J Gastroenterol; 2018 Feb; 53(2):165-171. PubMed ID: 29018965
[TBL] [Abstract][Full Text] [Related]
45. Eosinophilic esophagitis: updated consensus recommendations for children and adults.
Liacouras CA; Furuta GT; Hirano I; Atkins D; Attwood SE; Bonis PA; Burks AW; Chehade M; Collins MH; Dellon ES; Dohil R; Falk GW; Gonsalves N; Gupta SK; Katzka DA; Lucendo AJ; Markowitz JE; Noel RJ; Odze RD; Putnam PE; Richter JE; Romero Y; Ruchelli E; Sampson HA; Schoepfer A; Shaheen NJ; Sicherer SH; Spechler S; Spergel JM; Straumann A; Wershil BK; Rothenberg ME; Aceves SS
J Allergy Clin Immunol; 2011 Jul; 128(1):3-20.e6; quiz 21-2. PubMed ID: 21477849
[TBL] [Abstract][Full Text] [Related]
46. Eosinophilic esophagitis.
Dellon ES
Gastroenterol Clin North Am; 2013 Mar; 42(1):133-53. PubMed ID: 23452635
[TBL] [Abstract][Full Text] [Related]
47. Monoclonal Antibodies for Treatment of Eosinophilic Esophagitis.
Eskian M; Khorasanizadeh M; Assa'ad AH; Rezaei N
Clin Rev Allergy Immunol; 2018 Aug; 55(1):88-98. PubMed ID: 29234969
[TBL] [Abstract][Full Text] [Related]
48. From genetics to treatment of eosinophilic esophagitis.
Cianferoni A; Spergel JM
Curr Opin Allergy Clin Immunol; 2015 Oct; 15(5):417-25. PubMed ID: 26258919
[TBL] [Abstract][Full Text] [Related]
49. Efficacy of a 4-Food Elimination Diet for Children With Eosinophilic Esophagitis.
Kagalwalla AF; Wechsler JB; Amsden K; Schwartz S; Makhija M; Olive A; Davis CM; Manuel-Rubio M; Marcus S; Shaykin R; Sulkowski M; Johnson K; Ross JN; Riffle ME; Groetch M; Melin-Aldana H; Schady D; Palac H; Kim KA; Wershil BK; Collins MH; Chehade M
Clin Gastroenterol Hepatol; 2017 Nov; 15(11):1698-1707.e7. PubMed ID: 28603055
[TBL] [Abstract][Full Text] [Related]
50. Eosinophilic Esophagitis: A Comprehensive Review.
Cianferoni A; Spergel J
Clin Rev Allergy Immunol; 2016 Apr; 50(2):159-74. PubMed ID: 26194940
[TBL] [Abstract][Full Text] [Related]
51. Eosinophilic Esophagitis: Existing and Upcoming Therapies in an Age of Emerging Molecular and Personalized Medicine.
Slack IF; Schwartz JT; Mukkada VA; Hottinger S; Abonia JP
Curr Allergy Asthma Rep; 2020 Jun; 20(8):30. PubMed ID: 32506181
[TBL] [Abstract][Full Text] [Related]
52. The management of eosinophilic esophagitis in adults.
Segal D; Chande N
J Clin Gastroenterol; 2013 Aug; 47(7):570-7. PubMed ID: 23507765
[TBL] [Abstract][Full Text] [Related]
53. Review article: Emerging insights into the epidemiology, pathophysiology, diagnostic and therapeutic aspects of eosinophilic oesophagitis and other eosinophilic gastrointestinal diseases.
Low EE; Dellon ES
Aliment Pharmacol Ther; 2024 Feb; 59(3):322-340. PubMed ID: 38135920
[TBL] [Abstract][Full Text] [Related]
54. Management guidelines of eosinophilic esophagitis in childhood.
Papadopoulou A; Koletzko S; Heuschkel R; Dias JA; Allen KJ; Murch SH; Chong S; Gottrand F; Husby S; Lionetti P; Mearin ML; Ruemmele FM; Schäppi MG; Staiano A; Wilschanski M; Vandenplas Y;
J Pediatr Gastroenterol Nutr; 2014 Jan; 58(1):107-18. PubMed ID: 24378521
[TBL] [Abstract][Full Text] [Related]
55. Esophageal functional impairments in experimental eosinophilic esophagitis.
Mavi P; Rajavelu P; Rayapudi M; Paul RJ; Mishra A
Am J Physiol Gastrointest Liver Physiol; 2012 Jun; 302(11):G1347-55. PubMed ID: 22361731
[TBL] [Abstract][Full Text] [Related]
56. Severity of endoscopically identified esophageal rings correlates with reduced esophageal distensibility in eosinophilic esophagitis.
Chen JW; Pandolfino JE; Lin Z; Ciolino JD; Gonsalves N; Kahrilas PJ; Hirano I
Endoscopy; 2016 Sep; 48(9):794-801. PubMed ID: 27200524
[TBL] [Abstract][Full Text] [Related]
57. Elevated IL-33 expression is associated with pediatric eosinophilic esophagitis, and exogenous IL-33 promotes eosinophilic esophagitis development in mice.
Judd LM; Heine RG; Menheniott TR; Buzzelli J; O'Brien-Simpson N; Pavlic D; O'Connor L; Al Gazali K; Hamilton O; Scurr M; Collison AM; Mattes J; Allen KJ; Giraud AS
Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G13-25. PubMed ID: 26514775
[TBL] [Abstract][Full Text] [Related]
58. Evidence-based treatments for eosinophilic esophagitis: insights for the clinician.
Feo-Ortega S; Lucendo AJ
Therap Adv Gastroenterol; 2022; 15():17562848211068665. PubMed ID: 35069803
[TBL] [Abstract][Full Text] [Related]
59. The Role of the Environment in Eosinophilic Esophagitis.
Dowling PJ; Neuhaus H; Polk BI
Clin Rev Allergy Immunol; 2019 Dec; 57(3):330-339. PubMed ID: 30032346
[TBL] [Abstract][Full Text] [Related]
60. Biologics in eosinophilic esophagitis.
Zhang S; Assa'ad AH
Curr Opin Allergy Clin Immunol; 2021 Jun; 21(3):292-296. PubMed ID: 33769314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
